. Evaluation of antimicrobial activity of eburicol against human pathogenic bacteria (n = 3). Values should be compared to the standard Streptomycin results (12 ± 2 at 50 µg/mL and 15 ± 2 at 100 µg/mL for all strains). Table S1 . Evaluation of antimicrobial activity of eburicol against human pathogenic bacteria (n = 3). Values should be compared to the standard Streptomycin results (12 ± 2 at 50 µg/mL and 15 ± 2 at 100 µg/mL for all strains).
Strains
Inhibition zone (mm) (1) after treatment with eburicol 50 µg/mL 100 µg/mL B. cereus 10 ± 1 11 ± 1
Bacillus sp. 8 ± 0 12 ± 1 L. ivanovii 10 ± 1 9 ± 1 S. aureus 7 ± 0 24 ± 4 C. freundii 8 ± 1 11 ± 2 E. coli 10 ± 1 ND Salmonella spp. 9 ± 1 8 ± 2
(1): Ø ≤ 8mm: no significant antimicrobial activity; 8 < Ø ≤ 12 mm: weak antimicrobial activity; 12 < Ø ≤ 14 mm: significant antimicrobial activity; Ø > 14 mm: high antimicrobial activity. ND: not determined
